Congress 2017

International Faculty

Professor Jesus Rodriguez-Bano(Spain)
Dr Manica Balasegaram (Switzerland)
Professor David Durrheim (Australia)
Dr Rob Davidson (UK)
Professor Willem Hanekom (USA)
Professor Stephan Harbarth (Switzerland)
Professor Larry Madoff (USA)
Professor Nuala McGrath (UK)
Dr Mosepele Mosepele (Botswana)
Professor Edward Nardell(USA)
Professor Oyewale Tomori(Nigeria)
Professor Mike Sharland(UK)
Professor Jacques Ravel (USA)

Professor Jesus Rodriguez-Bano (Spain)
Professor Jesús Rodríguez-Baño is President-elect and Secretary General of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). He is Head of the Infectious Diseases Division at Hospital Universitario Virgen Macarena in Seville, Spain, and Professor of Medicine at the University of Seville; Chair of the Spanish Network for Research in Infectious Diseases (REIPI), funded by the Spanish Ministry of Health and Associate-Editor of Clinical Microbiology and Infection.

He has been appointed as member of the Scientific Advisory Board of the Joint Programme Initiative on Antimicrobial of the European Union. His main areas of interest in research are multi-drug resistant bacteria (molecular basis, clinical implications, therapy and control) and healthcare-related infections. Professor Rodríguez-Baño is author of more than 250 peer-reviewed articles in scientific journals and leads or participate several European research projects.

Professor David Durrheim (Australia)
David Durrheim is the Director of Health Protection, Hunter New England, Australia and Professor of Public Health Medicine at Newcastle University. Originally from South Africa where he obtained his first degrees from the Universities of Pretoria and Witwatersrand, Professor Durrheim trained in Public Health Medicine in England and Australia, has a Doctorate in Public Health and is a Fellow of the Royal Australasian College of Tropical Medicine, the Royal Society of Tropical Medicine and Hygiene and the Australasian Faculty of Public Health Medicine. He is the author of nearly 300 peer-reviewed articles and has published several scientific monographs and book chapters.

Professor Durrheim serves as an expert advisor to the WHO Western Pacific Regional Office on the implementation of the International Health Regulations in Pacific Island Countries and Territories and the Technical Advisory Group on Immunisation. He has served on the World Health Organisation’s Strategic Advisory Group of Experts (SAGE) on Immunisation. Current chair of the Regional Verification Commission for Measles and Rubella in the Western Pacific Region he and serves on the SAGE Measles and Rubella Working Group. Professor Durrheim’s vision is for a world where no child dies of measles.

Stephan Harbarth (Switzerland)
Stephan Harbarth obtained his medical degree from Ludwig-Maximilians University, Munich, Germany, in 1993 and completed his residency in internal medicine and tropical medicine at Munich University Hospitals. After serving as a clinical fellow in the Infectious Diseases Division and Infection Control Program in the Department of Internal Medicine at Geneva University Hospitals, Dr Harbarth completed his master’s degree in epidemiology at Harvard University in Boston, USA. He is board certified in infectious diseases and was appointed associate professor at the University of Geneva in 2010. Dr Harbarth’s work has garnered several awards, including the ICAAC Young Investigator Award from ASM (2003), the Young Investigator Award from ESCMID (2006), the Swiss Society for Infectious Diseases Award for epidemiological research (2008 & 2011) and the SHEA Investigator Award in 2011. Dr Harbarth has published over 80 peer-reviewed orginal research articles and has been cited 11,951 times without self-citations.

His research group is currently conducting several clinical and epidemiological studies to evaluate key questions related to the control of the acquisition, transmission and infection by multidrug-resistant microorganisms and participate in several ongoing large-scale EU-funded studies.

Larry Madoff (USA)
Larry Madoff is an infectious disease physician specialising in the epidemiology of emerging pathogens, bacterial pathogenesis and international health. He is Professor of Medicine at the University of Massachusetts Medical School and Lecturer on Medicine at Harvard Medical School. Dr Madoff serves as the Director of Epidemiology and Immunisation and Deputy State Epidemiologist for the Massachusetts Department of Public Health. He has directed ProMED, the Programme for Monitoring Emerging Diseases, since 2002.

His memberships include the American Society for Microbiology, the International Society for Infectious Diseases, the Massachusetts Medical Society, past President of the U.S. Lancefield Streptococcal Research Society, a Fellow of the Infectious Diseases Society of America and a Fellow of the American College of Physicians. A graduate of Yale College and Tufts Medical School, Dr Madoff performed his Internal Medicine Residency at New York Hospital-Cornell Medical Center and his Infectious Disease Fellowship at the Harvard Medical School-Longwood programme.

Mosepele Mosepele MD, MSc
Mosepele Mosepele MD, MSc, is a Senior Lecturer & Acting Assistant Programme Director (Convener of Master of Medicine, Internal Medicine) at the University of Botswana Faculty of Medicine, is a Specialist Physician, Infectious Disease Consultant and Clinical Epidemiologist with experience in research focused on HIV-associated complications such as cardiovascular disease, immune dysregulation plus HIV treatment and care. His most current end-organ work has focused on predicting risk factors for CVD (atherosclerotic versus non-atherosclerotic), neurocognitive impairment among virally suppressed HIV-infected patients, plus the role of gut dysbiosis in persistent inflammation despite viral suppression among HIV-infected patients in Botswana. His work on HIV treatment and care has focused on (1) the link between HIV drug metabolism (including role of host single nucleotide polymorphism) and clinical outcomes, and (2) use of social network theory to identify HIV patient treatment partner (treatment buddy) characteristics that are associated with viral suppression, among others.

Professor Edward Nardell

Professor Mike Sharland (UK)
Professor Mike Sharland is one of the UK and Europe’s leading experts in antimicrobial prescribing, resistance and healthcare associated infection in children. He has an interest in policy initiative to reduce the burden of antimicrobial resistance (AMR) and has been closely involved in the implementation of the National AMR Strategy. He has developed the Paediatric Infectious Diseases Unit at St George’s into a recognised Centre of excellence for clinical care, teaching and research and was appointed Professor of Paediatric Infectious Diseases in November 2010.

Prof Sharland chairs the Department of Health’s Expert Advisory Body on Antimicrobial Prescribing Resistance and Healthcare Associated Infection (APRHAI).

Professor Oyewale Tomori (Nigeria)
Professor Oyewale Tomori, is the immediate past President of the Nigerian Academy of Science. He has wide ranging experience in virology, disease prevention and control. He retired from the University of Ibadan in 1994 as a Professor of Virology and later served as the pioneer Vice Chancellor of the Redeemer’s University in Nigeria from 2004-2011. From 1994-2004, he was the Virologist for the WHO Africa Region, establishing the African Regional Polio Laboratory Network. Professor Tomori has an appreciable knowledge of arbovirus and viral hemorrhagic fever infections: Lassa Fever, Yellow Fever, and Viral Disease. In 1981, he was recognised by the US CDC for contribution to Lassa Fever research. In 2002, he received the Nigerian National Order of Merit, (NNOM), the country’s highest award for academic and intellectual attainment and national development.

In 2016, Professor Tomori was honoured with the African Society for Laboratory Medicine (ASLM), Lifetime Achievement Award for exceptional contribution to laboratory science. He has served and continues to serve on numerous advisory committees, including: WHO Africa Regional Polio Certification Committee, WHO Group of Experts on Yellow Fever Disease, Chairman WHO Yellow Fever Emergency Committee on International Health Regulations (IHR) and World Bank Working Group on Financing Preparedness and Response. He is an international member of the US National Academy of Medicine. Professor Tomori has published over 140 peer-reviewed articles in global publications in his areas of expertise.

Jacques Ravel, Ph.D
Dr Ravel is a Professor in the Department of Microbiology and Immunology and the Associate Director for Genomics at the Institute for Genome Sciences, University of Maryland School of Medicine in Baltimore, MD. His research program ( focuses on applying modern genomics technologies and ecological principles to characterise the role and dynamics of the microbial communities inhabiting the human body in health and disease and better define the interactions between the host, the microbes and the environment that drive these ecological systems. Specifically, he is interested in deciphering the role of the vaginal microbiome in women's health using clinical genomics and systems biology approaches, in order to develop improved strategy to manage gynaecological and obstetrics conditions. He is the co-Director of the NIH funded Collaborative Research Center on Sexually Transmitted Diseases entitled “Ecopathogenomics of Sexually Transmitted Diseases (EPSTI –” which aims at applying systems biology approaches to examine the triangular relationship between human genetic variation, sexually transmitted infections and co-infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae, and the function of the vaginal microbiome.

Dr Ravel received his Ph.D. degree from the University of Maryland College Park in Environmental Molecular Microbiology and Ecology and performed his postdoctoral training as a Ruth L. Kirschstein National Research fellow in the Chemistry Department at The Johns Hopkins University in Baltimore, MD working on the chemistry and bioinformatics natural products. He joined the Institute for Genome Sciences at the University of Maryland School of Medicine in 2007 as an Associate Professor. Previously, from 2002 to 2007 he was an Assistant Investigator at The Institute for Genomic Research (TIGR) in Rockville, MD, the pioneering institute where the first microbial genome was sequenced. He was elected to the American Academy of Microbiology in 2012. He is the Editor in Chief of the journal Microbiome.